Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Dysfunction-associated Steatotic Liver Disease/Steatohepatitis (MASLD/MASH)”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Not applicableNot Yet RecruitingNCT06795646
What this trial is testing

Clinical Classification of MAFLD Based Liver Biopsy

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseMetabolic Dysfunction-associated Steatohepatitis (MASH)
Beijing Friendship Hospital 2,000
Large-scale testing (Phase 3)Looking for participantsNCT06419374
What this trial is testing

Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc. 762
Not applicableLooking for participantsNCT06868992
What this trial is testing

Study of the Link Between MASH ( Metabolic Dysfunction-Associated Steatohepatitis) and MAMs (Mitochondria-Associated Membranes ) Alteration in Patients Undergoing Bariatric Surgery - MAMBA

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated SteatohepatitisSleeve Gastrectomy+1 more
Hospices Civils de Lyon 20
Not applicableLooking for participantsNCT07313007
What this trial is testing

Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)
Hospices Civils de Lyon 24
Early research (Phase 1)Study completedNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 115
Post-approval studies (Phase 4)Active Not RecruitingNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Large-scale testing (Phase 3)WithdrawnNCT06692283
What this trial is testing

Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH

Who this might be right for
MASLDMASHNASH+4 more
Sagimet Biosciences Inc.
Large-scale testing (Phase 3)Looking for participantsNCT06318169
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. 1,350
Not applicableLooking for participantsNCT07070362
What this trial is testing

Digital Early Warning System for Acute Lung Injury in Liver Surgery

Who this might be right for
Acute Lung Injury(ALI)Liver CirrhosisARDS, Human+4 more
Beijing Tsinghua Chang Gung Hospital 3,000
Early research (Phase 1)Looking for participantsNCT06704516
What this trial is testing

COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study

Who this might be right for
MenopauseMetabolic Dysfunction Associated Steatotic Liver Disease
University of Oxford 10
Not applicableStudy completedNCT06647095
What this trial is testing

New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
HealthySimple Steatosis (SS)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
General University Hospital, Prague 172
Early research (Phase 1)Looking for participantsNCT07807059
What this trial is testing

A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment

Who this might be right for
Overweight/ObesityMetabolic Dysfunction-associated Steatotic Liver Disease/Steatohepatitis (MASLD/MASH)Type 2 Diabetes Mellitus
Fujian Shengdi Pharmaceutical Co., Ltd. 32
Testing effectiveness (Phase 2)Looking for participantsNCT07527910
What this trial is testing

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 204
Not applicableLooking for participantsNCT07476703
What this trial is testing

Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

Who this might be right for
Coronary Artery DiseaseArterial Stiffness, Blood PressureAORTIC VALVE DISEASES+9 more
Danderyd Hospital 1,400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07025980
What this trial is testing

Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Diabetes MellitusHypertension+1 more
Eva Cubric
Not applicableLooking for participantsNCT06138821
What this trial is testing

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Who this might be right for
ObesityLiver DiseasesLiver Fibrosis+16 more
Pichamol Jirapinyo, MD, MPH 132
Post-approval studies (Phase 4)Looking for participantsNCT07058155
What this trial is testing

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

Who this might be right for
Liver CirrhosesPortal Hypertension Related to CirrhosisSevere Obesity+1 more
The Cleveland Clinic 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631637
What this trial is testing

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Regeneron Pharmaceuticals 150
Testing effectiveness (Phase 2)Looking for participantsNCT05519475
What this trial is testing

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Who this might be right for
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Regeneron Pharmaceuticals 120
Not applicableEnrolling By InvitationNCT06986447
What this trial is testing

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
HRI-MAIL-NIT 1,689
Next Page
114